Sort
51,593 grants matching “hepatitis”
Multifidelity and multiscale modeling of the spleen function in sickle cell disease with in vitro, ex vivo and in vivo validations
$636,323George Karniadakis · Brown University · R01 · FY2023 · HL
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
$636,299Hashem B El-Serag · Baylor College Of Medicine · R01 · FY2016 · CA
Discovery and Assessment of Genetic Determinants of HCV and HIV Control
$636,115Raymond T Chung · Massachusetts General Hospital · R01 · FY2015 · DA
Role of FGF23 peptides in chronic kidney disease (CKD)
$636,094Nicolae Valentin David · Northwestern University At Chicago · R01 · FY2023 · DK
International Consortium for the Genetics of Biliary Tract Cancers Cholangiocarcinoma Genome Wide Association Study
$636,071Lewis R Roberts · Mayo Clinic Rochester · U01 · FY2024 · CA
Mapping Disease Pathways for Biliary Atresia
$636,062Rakesh K. Sindhi · University Of Pittsburgh At Pittsburgh · R01 · FY2018 · DK
Role of African-centric TP53 variant in higher H. pylori prevalence in African Americans
$636,016Daniel Thomas Claiborne · Wistar Institute · R01 · FY2021 · DK
Colorado Center of Childhood Liver Disease Research Network
$636,000Ronald J Sokol · University Of Colorado Denver · U01 · FY2023 · DK
Synergy of Hydroxyurea and Erythropoietin on Fetal Hemoglobin in SCD
$635,991Mark Thomas Gladwin · National Heart, Lung, And Blood Institute · Z01 · FY2008 · HL
Cancer stem cells and human liver cancer
$635,990Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Leveraging electronic medical records to perform large-scale diabetes pharmacogenomics among ancestrally diverse patient populations
$635,940Keoki Williams · Henry Ford Health System · R01 · FY2020 · DK
HIV Disease Outcomes in Drug Users in Clinical Practice
$635,932Richard Douglas Moore · Johns Hopkins University · R01 · FY2013 · DA
The Metabolic Impact of Congenital Heterozygous ApoC-III Deficiency in Humans
$635,842Toni I. Pollin · University Of Maryland Baltimore · R01 · FY2011 · HL
Soluble epoxide hydrolase-regulated lipid signaling in Alzheimerâs disease
$635,794Izumi Maezawa · University Of California At Davis · R01 · FY2024 · AG
TARGETING MASH WITH NOVEL SMALL MOLECULE TXNIP INHIBITOR
$635,709Anath Shalev · University Of Alabama At Birmingham · R01 · FY2025 · DK
HBV Capsid Effectors
$635,652Raymond F. Schinazi · Emory University · R56 · FY2021 · AI
We are here now - a multi-level, multi-component sexual and reproductive health intervention for American Indian youth
$635,647Elizabeth Lynne Rink · Montana State University - Bozeman · R01 · FY2019 · MD
Sex-Specific Roles of L-PK in Cholesterol Metabolism and Atherosclerosis
$635,631Karthickeyan Chella Krishnan · University Of Cincinnati · R01 · FY2024 · HL
Dynamic Strategies for the clinical management of HIV disease
$635,624Miguel Hernan · Harvard School Of Public Health · R37 · FY2023 · AI
Quantitative ECT for Complex Imaging Tasks
$635,422Stephen C Moore · Brigham And Women'S Hospital · R01 · FY2009 · EB
The Role of Iron in the Pathogenesis of NAFLD
$635,347Kris Kowdley · Benaroya Research Inst At Virginia Mason · R01 · FY2012 · DK
Discovery of novel therapeutic targets for NASH through deep phenotyping of human knockouts and mechanistic studies
$635,329Danish Saleheen · Columbia University Health Sciences · R01 · FY2024 · DK
Epigenomics of Air Pollution driven Inflammation, Obesity and Insulin Resistance
$635,267Shyam Biswal · Johns Hopkins University · U01 · FY2019 · ES
LIVOPT -- LIVer cirrhosis - Optimizing Prediction of Patient OuTcomes
$635,054Daniela P Ladner · Northwestern University At Chicago · R01 · FY2022 · AG
Antimanic Use During Pregnancy
$635,032Katherine L. Wisner · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · MH